Ascend supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form.
Provider of a wellness card intended to keep customers healthy. The company specializes in creating health cards that earn rewards for healthy purchases and access perks to complement their lifestyle, enabling users to get free sessions at their favorite workout studios and discounts on health and wellness subscriptions.
Terray Therapeutics, Inc. operates as a biotechnology company. The company develops treatments for intractable cause of human diseases. It engages in development of a screening platform for drug discovery and Platinum Technology, which is working on an electrode-like product for deep brain stimulation. The company was founded in 2018 and is based in Pasadena, California.
Faeth Therapeutics is a healthcare company dedicated to enhancing cancer treatment through a deep understanding of the relationship between dietary nutrients and tumor growth. By aligning specific diets with tumor genotypes and treatment regimens, Faeth aims to limit the energy and resources that tumors need to proliferate, thereby improving patient outcomes in cancer therapy. Founded by leading researchers and clinicians, the company seeks to translate significant discoveries from cancer research laboratories into effective clinical practices, focusing on evidence-based approaches to optimize treatment strategies for cancer patients.
Good Therapeutics, Inc. is a biotechnology company based in Seattle, Washington, founded in 2016. The company specializes in the development of biotherapeutics and self-regulating drugs that deliver therapeutic effects precisely when and where needed. Its innovative approach involves creating context-dependent protein drugs that can sense biomarkers and respond accordingly, thus minimizing systemic toxicity while maintaining therapeutic efficacy. Good Therapeutics employs an algorithm designed for allosterically-regulated proteins, which alter their shape upon binding with specific biomarkers or metabolites, activating their therapeutic functions. The company's primary focus is on applications within immuno-oncology, aiming to enhance treatment outcomes while ensuring patient safety.
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at the Harvard Life Lab, a shared laboratory space for high-potential life sciences and biotechnology startups founded by Harvard faculty, alumni, students, and postdoctoral scholars.
We leverage our patent-pending technology to produce nutritionally equivalent breastmilk from cultured human mammary cells. With Biomilq, families can achieve the recommended six months of exclusive breastfeeding while alleviating the climate impacts of bovine-based infant formula.
Scout Bio, Inc. researches and develops one-time therapies for major chronic pet health conditions using veterinary biotechnology and gene therapy. It offers therapies for anemia associated with chronic kidney disease (CKD) in cats. The company offers pet therapeutics, including small molecular drugs, protein therapies, and gene therapies. Scout Bio, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.
Kingdom Supercultures specializes in developing and producing microbial cultures that assist food manufacturers in creating innovative food products. Founded in 2019 and based in Brooklyn, New York, the company is known for its production of Koji, a traditional Japanese ingredient essential for making miso, sake, and soy sauce, among other applications. In addition to Koji, Kingdom Supercultures offers a range of functional ingredients and biopreservatives, contributing to the production of fermented sodas, beers, and plant-based dairy alternatives. Their unique platform utilizes software and hardware automation to explore the extensive microbial diversity found in nature, enabling the discovery and assembly of new microbial food strains into cultures. This approach supports brands in their efforts to develop healthy and sustainable food options without resorting to synthetic engineering.
UnifiHealth is reimagining how health benefits are built and delivered to small businesses. The company was founded in 2019 and based in Columbus, Ohio.
PetMedix Ltd is a veterinary biopharmaceutical company based in Cambridge, UK, focused on developing therapeutic drug discovery tools and platforms for pets. Founded in 2017, the company specializes in creating transgenic mouse platforms, such as Ky9 and Felyne, which produce therapeutic-quality antibody drugs specifically tailored for companion animals. Leveraging over thirty years of expertise in human drug development, PetMedix aims to generate a diverse repertoire of monoclonal antibodies that aligns with the immune systems of pets. This innovation enables veterinary professionals to provide effective and safe treatments, ultimately contributing to the health and well-being of animals.
Cayaba Care is a maternal health company focused on providing comprehensive support throughout all phases of pregnancy. The company offers community-based clinical services that are enhanced by technology-enabled multidisciplinary care teams. Its platform addresses a range of concerns including mental health, breastfeeding difficulties, spotting, and postpartum follow-up needs. By focusing on alleviating symptoms, pain, and overall stress and anxiety associated with pregnancy, Cayaba Care aims to ensure that women experience a healthy and safe pregnancy journey.
Terray Therapeutics, Inc. operates as a biotechnology company. The company develops treatments for intractable cause of human diseases. It engages in development of a screening platform for drug discovery and Platinum Technology, which is working on an electrode-like product for deep brain stimulation. The company was founded in 2018 and is based in Pasadena, California.
AnimalBiome focuses on improving the gut health of dogs and cats in the United States that suffer from chronic digestive disorders. The company offers microbiome-based supplements and non-invasive diagnostic tools designed to identify imbalances in the gut microbiome. Utilizing deoxyribonucleic acid sequencing, AnimalBiome's diagnostic services assess the balance of gut bacteria, allowing pet owners to gain insights into their pets' gut health. This information enables tailored supplementation aimed at restoring gut balance, ultimately promoting a healthier and happier life for pets.
Aunt Bertha is a Public Benefit Corporation that operates a social services search and referrals software platform designed to help individuals locate various welfare programs. Founded in 2010 and based in Austin, Texas, the company provides users with access to resources related to food, shelter, healthcare, employment, and financial assistance. The platform facilitates connections between those in need and available support services, streamlining the process of finding and applying for government and charitable programs. Aunt Bertha serves a diverse range of sectors, including healthcare, education, government, and child welfare, effectively reducing the administrative costs associated with social service program management by enabling online applications.
Code Ocean, Inc. operates a cloud-based platform that facilitates the sharing, discovery, and execution of code and data in academic research. Founded in 2015 and based in New York, the platform supports researchers and developers by offering an open access environment where published software code can be easily accessed and run without the need for local installations. This end-to-end workflow solution enhances reproducibility by allowing users to compile all necessary code, data, and dependencies into a single self-contained compute capsule. The platform is designed to promote collaboration, enabling researchers to document their methodologies and ensure transparency in their computational processes. By providing tools that streamline research from inception to publication, Code Ocean empowers users across various fields, particularly bioinformatics and biology, to reproduce and build upon existing research findings.
Brella is modernizing supplemental health benefits to build a world where health hardship doesn’t mean financial hardship. Brella’s simple supplemental plan covers 13,000+ conditions and pays cash on the diagnosis that you can use for anything that is needed on the road to recovery. Brella Insurance was founded in 2019 and is based in Hoboken, New Jersey.
Rejuvenate Bio Inc is a biotechnology company based in Brookline, Massachusetts, founded in 2017. The company specializes in developing gene therapies aimed at enhancing the health and longevity of domesticated animals, particularly dogs. Rejuvenate Bio offers anti-aging treatments by introducing new DNA instructions into the animals' bodies. Additionally, the company provides gene therapies designed to target and cure specific diseases in pets, contributing to improved overall well-being and lifespan.
SeQure Dx
Venture Round in 2021
SeQure DX is in the business activities at non-commercial site business. It was founded in 2020 and is based in Waltham, Massachusetts.
UnifiHealth is reimagining how health benefits are built and delivered to small businesses. The company was founded in 2019 and based in Columbus, Ohio.
Onc AI, founded in 2020 and based in San Carlos, California, specializes in clinical oncology and offers a precision oncology clinical management platform. The company focuses on enhancing decision-making in cancer care through a comprehensive approach that encompasses genomics, proteomics, and radiomics. By leveraging deep learning technologies, Onc AI aims to provide actionable insights that empower healthcare providers in the effective treatment of cancer.
Nuperfect is a company that specializes in designing and developing invisible orthodontic devices, specifically custom braces for teeth correction. Utilizing advanced technologies such as artificial intelligence, cloud computing, 3D reconstruction, and 3D printing, Nuperfect creates personalized correction solutions based on three-dimensional digital dental models. Additionally, the company offers offline dental scanning and home dental mold tools to facilitate data collection for its products. Customers can access Nuperfect's services and products through an online portal. Founded in 2019, Nuperfect is headquartered in Shenzhen, China.
Brella is modernizing supplemental health benefits to build a world where health hardship doesn’t mean financial hardship. Brella’s simple supplemental plan covers 13,000+ conditions and pays cash on the diagnosis that you can use for anything that is needed on the road to recovery. Brella Insurance was founded in 2019 and is based in Hoboken, New Jersey.
Smalls is a direct-to-consumer pet food company based in New York that specializes in producing fresh, human-grade food for cats. Founded in 2017 by Matt Michaelson and Calvin, the company offers a range of cat food options, including chicken, beef, turkey, and duck, which are prepared with fresh meat and a small amount of green vegetables. The food is gently cooked to preserve nutrients and moisture, ensuring high quality. Smalls provides customized meal kits tailored to the specific nutritional needs of each cat, allowing pet owners to conveniently receive healthy and fresh food delivered directly to their homes.
Base5 Genomics, Inc. is a biotechnology firm that specializes in developing sequencing solutions aimed at enhancing personalized healthcare. Founded in 2018 and headquartered in Palo Alto, California, the company focuses on uncovering the full genomic diversity in humans and other organisms. Its innovative technologies are particularly relevant to cancer biology, DNA damage and repair, genome organization, and gene regulation, allowing the medical community to advance personalized treatment strategies for patients. By providing comprehensive genomic insights, Base5 Genomics contributes to the evolving landscape of personalized medicine.
Good Therapeutics, Inc. is a biotechnology company based in Seattle, Washington, founded in 2016. The company specializes in the development of biotherapeutics and self-regulating drugs that deliver therapeutic effects precisely when and where needed. Its innovative approach involves creating context-dependent protein drugs that can sense biomarkers and respond accordingly, thus minimizing systemic toxicity while maintaining therapeutic efficacy. Good Therapeutics employs an algorithm designed for allosterically-regulated proteins, which alter their shape upon binding with specific biomarkers or metabolites, activating their therapeutic functions. The company's primary focus is on applications within immuno-oncology, aiming to enhance treatment outcomes while ensuring patient safety.
Kenzen, Inc. specializes in developing personal health wearables, notably the Kenzen ECHO, a wireless smart patch designed for health and performance monitoring. This innovative patch offers personalized health insights and notifications that aid in improving performance, recovery, and injury prevention. The ECHO system includes components such as disposable patch sensors, a USB charging cable, and a mobile application that provides real-time data on users' performance and health. Kenzen's technology serves various sectors, including industrial environments, where it helps monitor vital signs to prevent heat-related injuries and over-exertion. The company, founded in 2014 by Sonia Sousa and Steve Pecko, operates from San Francisco, California, and distributes its products through various channels, including resellers and retail locations.
Scratch Financial, operating under the brand Scratchpay, is the leading provider of accessible payment plans for veterinary care in the United States. Established in 2016 by Caleb Morse and John Keatley, the company is based in Los Angeles, California. Scratchpay collaborates with veterinary clinics to offer pet owners straightforward and pet-friendly financing options. The platform allows users to apply for and receive approval for payment plans in approximately 90 seconds, facilitating timely access to essential veterinary services. Scratchpay aims to enhance the affordability and transparency of veterinary care, ultimately ensuring that more pet owners can obtain the medical attention their animals require.
The Mighty is a digital health community designed to empower and connect individuals facing health challenges and disabilities. It provides a platform for users to share their personal experiences through stories and videos related to disability, disease, and mental illness. By fostering connections among users with similar experiences, The Mighty aims to create a supportive environment that encourages positivity and resilience in the face of adversity.
The Mighty is a digital health community designed to empower and connect individuals facing health challenges and disabilities. It provides a platform for users to share their personal experiences through stories and videos related to disability, disease, and mental illness. By fostering connections among users with similar experiences, The Mighty aims to create a supportive environment that encourages positivity and resilience in the face of adversity.
Aunt Bertha is a Public Benefit Corporation that operates a social services search and referrals software platform designed to help individuals locate various welfare programs. Founded in 2010 and based in Austin, Texas, the company provides users with access to resources related to food, shelter, healthcare, employment, and financial assistance. The platform facilitates connections between those in need and available support services, streamlining the process of finding and applying for government and charitable programs. Aunt Bertha serves a diverse range of sectors, including healthcare, education, government, and child welfare, effectively reducing the administrative costs associated with social service program management by enabling online applications.
Code Ocean, Inc. operates a cloud-based platform that facilitates the sharing, discovery, and execution of code and data in academic research. Founded in 2015 and based in New York, the platform supports researchers and developers by offering an open access environment where published software code can be easily accessed and run without the need for local installations. This end-to-end workflow solution enhances reproducibility by allowing users to compile all necessary code, data, and dependencies into a single self-contained compute capsule. The platform is designed to promote collaboration, enabling researchers to document their methodologies and ensure transparency in their computational processes. By providing tools that streamline research from inception to publication, Code Ocean empowers users across various fields, particularly bioinformatics and biology, to reproduce and build upon existing research findings.
Kenzen, Inc. specializes in developing personal health wearables, notably the Kenzen ECHO, a wireless smart patch designed for health and performance monitoring. This innovative patch offers personalized health insights and notifications that aid in improving performance, recovery, and injury prevention. The ECHO system includes components such as disposable patch sensors, a USB charging cable, and a mobile application that provides real-time data on users' performance and health. Kenzen's technology serves various sectors, including industrial environments, where it helps monitor vital signs to prevent heat-related injuries and over-exertion. The company, founded in 2014 by Sonia Sousa and Steve Pecko, operates from San Francisco, California, and distributes its products through various channels, including resellers and retail locations.
Pawp, Inc. is a pet care service provider that offers an online platform designed to assist pet owners in managing their pets' health and accessing veterinary care. Founded in 2018 and based in New York, the company provides users with unlimited 24/7 access to licensed veterinarians, significantly reducing the need for unnecessary vet visits. Pawp also offers a pet emergency fund of $3,000 per year, which serves as a financial safety net for unexpected veterinary expenses. By combining veterinary access with emergency funding, Pawp aims to make pet care more affordable and accessible, allowing pet owners to make informed health decisions for their animals.
Scout Bio, Inc. researches and develops one-time therapies for major chronic pet health conditions using veterinary biotechnology and gene therapy. It offers therapies for anemia associated with chronic kidney disease (CKD) in cats. The company offers pet therapeutics, including small molecular drugs, protein therapies, and gene therapies. Scout Bio, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.
Terray Therapeutics, Inc. operates as a biotechnology company. The company develops treatments for intractable cause of human diseases. It engages in development of a screening platform for drug discovery and Platinum Technology, which is working on an electrode-like product for deep brain stimulation. The company was founded in 2018 and is based in Pasadena, California.
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at the Harvard Life Lab, a shared laboratory space for high-potential life sciences and biotechnology startups founded by Harvard faculty, alumni, students, and postdoctoral scholars.
PetMedix Ltd is a veterinary biopharmaceutical company based in Cambridge, UK, focused on developing therapeutic drug discovery tools and platforms for pets. Founded in 2017, the company specializes in creating transgenic mouse platforms, such as Ky9 and Felyne, which produce therapeutic-quality antibody drugs specifically tailored for companion animals. Leveraging over thirty years of expertise in human drug development, PetMedix aims to generate a diverse repertoire of monoclonal antibodies that aligns with the immune systems of pets. This innovation enables veterinary professionals to provide effective and safe treatments, ultimately contributing to the health and well-being of animals.
CareDox Inc. operates a care coordination platform designed to assist parents and schools in managing and sharing medical information effectively. Founded in 2010 and based in New York, the company focuses on streamlining the collection and accessibility of health data to enhance child safety. Its platform enables parents to organize their family's health information, eliminating the need for paper forms during school, camp, and daycare enrollment. Parents can selectively share health information while maintaining a secure record of their children's medical history. For schools, CareDox facilitates the medical enrollment process, ensuring compliance with safety requirements and providing school staff, including nurses and teachers, with essential health information about students. This access allows for real-time insights into allergies, medications, and special dietary needs, ultimately improving health outcomes and supporting the continuity of care for children in the K-12 education system.
Good Therapeutics, Inc. is a biotechnology company based in Seattle, Washington, founded in 2016. The company specializes in the development of biotherapeutics and self-regulating drugs that deliver therapeutic effects precisely when and where needed. Its innovative approach involves creating context-dependent protein drugs that can sense biomarkers and respond accordingly, thus minimizing systemic toxicity while maintaining therapeutic efficacy. Good Therapeutics employs an algorithm designed for allosterically-regulated proteins, which alter their shape upon binding with specific biomarkers or metabolites, activating their therapeutic functions. The company's primary focus is on applications within immuno-oncology, aiming to enhance treatment outcomes while ensuring patient safety.
MollyBox is a subscription-based e-commerce platform for pet-owners. The company offers a monthly themed box of pet foods and supplies. MollyBox was founded in 2015 by Yifu Sun and Yi Ju and is based in Shanghai, China.
Girihlet Inc. is a genetic-sequencing company based in Oakland, California, established in 2012. It specializes in providing rapid and accurate deep sequencing services, focusing on non-canonical genomics solutions. The company employs novel, bias-free methods to inexpensively sequence and analyze mitochondrial DNA and T cell receptors. By profiling the T cell receptor repertoire, Girihlet aims to improve understanding of the immune system, particularly in relation to T-cell-driven autoimmune conditions. The company leverages deep sequencing and machine learning to decode individual immune responses, thereby guiding therapeutic strategies and enhancing diagnostic capabilities for various disorders. Through its patented technologies, Girihlet seeks to make a significant impact in clinical settings and advance basic research in immunology.
Rejuvenate Bio Inc is a biotechnology company based in Brookline, Massachusetts, founded in 2017. The company specializes in developing gene therapies aimed at enhancing the health and longevity of domesticated animals, particularly dogs. Rejuvenate Bio offers anti-aging treatments by introducing new DNA instructions into the animals' bodies. Additionally, the company provides gene therapies designed to target and cure specific diseases in pets, contributing to improved overall well-being and lifespan.
Scratch Financial, operating under the brand Scratchpay, is the leading provider of accessible payment plans for veterinary care in the United States. Established in 2016 by Caleb Morse and John Keatley, the company is based in Los Angeles, California. Scratchpay collaborates with veterinary clinics to offer pet owners straightforward and pet-friendly financing options. The platform allows users to apply for and receive approval for payment plans in approximately 90 seconds, facilitating timely access to essential veterinary services. Scratchpay aims to enhance the affordability and transparency of veterinary care, ultimately ensuring that more pet owners can obtain the medical attention their animals require.
Kenzen, Inc. specializes in developing personal health wearables, notably the Kenzen ECHO, a wireless smart patch designed for health and performance monitoring. This innovative patch offers personalized health insights and notifications that aid in improving performance, recovery, and injury prevention. The ECHO system includes components such as disposable patch sensors, a USB charging cable, and a mobile application that provides real-time data on users' performance and health. Kenzen's technology serves various sectors, including industrial environments, where it helps monitor vital signs to prevent heat-related injuries and over-exertion. The company, founded in 2014 by Sonia Sousa and Steve Pecko, operates from San Francisco, California, and distributes its products through various channels, including resellers and retail locations.
Elemental Machines, Inc. is a technology company based in Cambridge, Massachusetts, founded in 2014. The company focuses on enhancing laboratory operations in science-based industries through its smart lab platform, which delivers data-driven insights. By continuously monitoring equipment and environmental variables, Elemental Machines aims to improve clarity, transparency, and consistency in research, development, and manufacturing processes. This approach not only enhances repeatability but also enables the collection of new data sets for advanced analytics, ultimately revolutionizing the efficiency and effectiveness of laboratory operations.
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at the Harvard Life Lab, a shared laboratory space for high-potential life sciences and biotechnology startups founded by Harvard faculty, alumni, students, and postdoctoral scholars.
Kenzen, Inc. specializes in developing personal health wearables, notably the Kenzen ECHO, a wireless smart patch designed for health and performance monitoring. This innovative patch offers personalized health insights and notifications that aid in improving performance, recovery, and injury prevention. The ECHO system includes components such as disposable patch sensors, a USB charging cable, and a mobile application that provides real-time data on users' performance and health. Kenzen's technology serves various sectors, including industrial environments, where it helps monitor vital signs to prevent heat-related injuries and over-exertion. The company, founded in 2014 by Sonia Sousa and Steve Pecko, operates from San Francisco, California, and distributes its products through various channels, including resellers and retail locations.
Somatix Ltd. is a developer of wearable-assisted gesture detection solutions, focusing on real-time remote patient monitoring for healthcare applications. The company's platform utilizes patented gesture detection technology, artificial intelligence, and machine learning to analyze large volumes of gesture data. This enables the passive identification of physical and emotional indicators, such as risk factors for adverse events, inactivity, and medication non-compliance, thereby delivering valuable clinical insights to healthcare providers. Somatix offers products like SafeBeing, tailored for elderly care, and SmokeBeat, aimed at smoking cessation. The company's systems leverage existing sensors in commercial smartwatches and smartbands, as well as its own devices, to enhance patient monitoring and support personalized health interventions. Founded in 2015 and headquartered in Ra'anana, Israel, Somatix operates as a subsidiary of Somatix, Inc., which is based in New York.
CareDox Inc. operates a care coordination platform designed to assist parents and schools in managing and sharing medical information effectively. Founded in 2010 and based in New York, the company focuses on streamlining the collection and accessibility of health data to enhance child safety. Its platform enables parents to organize their family's health information, eliminating the need for paper forms during school, camp, and daycare enrollment. Parents can selectively share health information while maintaining a secure record of their children's medical history. For schools, CareDox facilitates the medical enrollment process, ensuring compliance with safety requirements and providing school staff, including nurses and teachers, with essential health information about students. This access allows for real-time insights into allergies, medications, and special dietary needs, ultimately improving health outcomes and supporting the continuity of care for children in the K-12 education system.
Second Genome’s mission is to transform lives with medicines developed through innovative microbiome science. Second Genome has built a novel platform for microbiome drug discovery. Second Genome has completed more than 400 microbiome studies, analyzing more than 75,000 samples, for internal R&D, as well as for external partners across government, academia, pharmaceutical, nutrition and industrial companies. The team leverages its microbiome analysis platform with its partners’ specific expertise to generate insightful findings that can accelerate research programs by elucidating the role of the microbiome in human health conditions, agriculture, animal health and other industries. The company has established a pipeline of therapeutic products for the treatment of inflammation and metabolic diseases.